Novel Technologies Driving Infectious Disease Management in 2019: Includes Growth Opportunities & Companies to Action – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Novel Technologies Driving Infectious Disease Management” report has been added to ResearchAndMarkets.com’s offering. This research service covers emerging diagnostic technologies that can transform infectious disease management. CRISPR-based diagnostics: CRISPR (clustered regularly interspaced short palindromic repeats) can deliver rapid, portable and accurate diagnostics tests for field applications. This report deals with two major US-based … [Read more…]

2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering Feat in Tackling Cancer with Immunotherapy

TOKYO–(BUSINESS WIRE)–The Edogawa NICHE Committee today announced that the 2019-Edogawa NICHE Prize (www.edogawanicheprize.org) has been awarded to Dr. Steven A. Rosenberg, for his pioneering work in developing effective adoptive immunotherapies and genetically modified T cells which has heralded the birth of a new chapter in the fight against cancer. Dr. Rosenberg’s accomplishment has significantly contributed … [Read more…]

Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced the pricing of its previously announced registered underwritten public offering of 10,810,810 shares of its common stock at a price to the public of $37.00 per share. The gross proceeds to Deciphera from the … [Read more…]

AHF Applauds Appointment of Winnie Byanyima as Head of UNAIDS

LOS ANGELES–(BUSINESS WIRE)–AHF lauded today a historic decision by the United Nations Secretary-General to appoint Winnie Byanyima as the new Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS). Byanyima, who is a prominent Ugandan diplomat and humanitarian, will be the first woman Executive Director to lead the agency since its launch in … [Read more…]

AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update

Moves into new San Francisco Bay Area R&D facility, comprising approximately 15,700-square-feet of office and lab space, including cGMP-capable manufacturing suite. Strengthens leadership at Board level by appointment of regenerative medicine leader Dr. Michael H. May, CEO of Canada’s Centre for Commercialization of Regenerative Medicine (CCRM). Begins work using synthetic biology approach to engineer pluripotent … [Read more…]

PatientPop Named to Inc. 5000

Achieves No. 125 ranking in first year of list eligibility SANTA MONICA, Calif.–(BUSINESS WIRE)–#doctors—PatientPop, the industry leader in practice growth technology, has been named to Inc. magazine’s annual Inc. 5000, the most prestigious ranking of the nation’s fastest-growing private companies. The list provides a unique look at the most successful companies within the American economy’s … [Read more…]

CORRECTING and REPLACING VeriSIM Life Raises $5.2M Round of Funding: Building Digital Animal and Human Simulations to Avoid Unnecessary Drug Testing in Animals

SAN FRANCISCO–(BUSINESS WIRE)–#ai–First paragraph, second sentence of release should read: Recently raising a $5.2M USD series seed co-led by OCA Ventures and Serra Ventures with participation from Susa Ventures, Intel Capital, Stage Venture Partners, Village Global, Twin, and Loup Ventures, the company will now be able to support increasingly larger communities in academia and pharma … [Read more…]

CEL-SCI Corporation Reports Third Quarter Fiscal 2019 Financial Results

VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2019. The Company also reported key clinical and corporate developments achieved during the quarter. Clinical and Corporate Developments included: CEL-SCI’s Phase 3 head and neck cancer study continued to follow all 928 patients who were enrolled. The Company … [Read more…]

Baxter to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York on September 9, 2019. José (Joe) Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 1:05 p.m. Eastern Time. The live webcast of Baxter’s presentation can … [Read more…]

cbdMD Reports Q3 Net Sales Increase 42% Sequentially to Over $8 Million

Company Provides Guidance of $24M-$26M in Net Sales for Fiscal Year Ending September 2019 Company Provides Guidance of $80M-$90M in Net Sales for Fiscal Year Ending September 2020 CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD), reported today that in its fiscal quarter ended June 30, 2019, the company generated total net sales of $8,044,000 up … [Read more…]